Indaba kaGentolex ingalandelelwa emuva ehlobo lika-2013, iqembu labantu abasha abanombono embonini wokudala amathuba axhumanisa umhlaba ngezinsizakalo ezingcono kanye nesiqinisekiso semikhiqizo.
Indawo yokwakhiwa kwefekthri iyonke engamamitha-skwele angu-250,000 ngaphansi kwendinganiso yamazwe ngamazwe ukunikeza izixazululo eziguquguqukayo, ezihlasimulisayo nezingabizi kakhulu.
I-Gentolex inikeza uhla olubanzi lwama-API kanye neziphakathi zokutadisha ukuthuthukiswa kanye nesicelo sokuhweba ngezinga le-cGMP kusukela ekusebenzisaneni isikhathi eside.Amadokhumenti nezitifiketi kusekelwa kumakhasimende emhlabeni jikelele.
Sinolwazi olucebile lokuhlinzeka ngezinsizakalo ze-CRO ne-CDMO kuyo yonke inqubo yokuthuthukiswa kwezidakamizwa ze-peptide kumaphrojekthi we-IND, NDA & ANDA, sinikeza isiqondiso esiphephile nesisebenzayo kusukela ekuthuthukisweni kuya ekukhiqizeni ezentengiselwano.
Kulawo maklayenti akhetha ukugwema inkimbinkimbi yokubhekana nezindawo eziningi zokuxhumana, sihlinzeka ngezinsizakalo zokuthenga ezenziwe ngokwezifiso ezengeziwe ngemithombo yochungechunge yokuhlinzeka ngezinto ephakeme kakhulu nephelele.
Indaba kaGentolex ingalandelelwa emuva ehlobo lika-2013, iqembu labantu abasha abanombono embonini wokudala amathuba axhumanisa umhlaba ngezinsizakalo ezingcono kanye nesiqinisekiso semikhiqizo.Kuze kube manje, ngeminyaka yokuqongelela, iGentolex Group ibilokhu isebenzela amakhasimende avela emazweni angaphezu kwe-15 kuwo wonke amazwekazi ayi-5, ikakhulukazi, amaqembu amele asungulwa eMexico naseNingizimu Afrika, maduze nje, kuzosungulwa amaqembu amaningi amele izinsizakalo zebhizinisi.
Ngo-2021-12-06, isikhathi sase-US, i-Acadia Pharmaceuticals (Nasdaq: ACAD) yamemezela imiphumela emihle ephezulu yokuhlolwa kwayo komtholampilo kweSigaba III sekhandidethi layo lezidakamizwa, i-Trofinetide.Uhlolo lwesigaba III, olubizwa nge-Lavender, lusetshenziswa kakhulu ukuhlola ukuphepha nokusebenza kwe-Trofinetide ekwelapheni i-Ret...
Kusukela ngo-2021-08-24, i-Cara Therapeutics kanye nozakwabo ebhizinisini u-Vifor Pharma bamemezele ukuthi i-kappa opioid receptor agonist ye-felikefalin (KORSUVA™) yesigaba sokuqala yagunyazwa yi-FDA yokwelapha iziguli ezinesifo sezinso (CKD) esingalapheki. (i-pruritus enhle emaphakathi/enzima ene-hemod...
Isikhathi saseCanada i-2022-01-24, i-RhoVac, inkampani eyenza imithi egxile ku-tumor immunology, yamemezela ukuthi isicelo sayo selungelo lobunikazi (No.Ngaphambilini, inkampani ithole amalungelo obunikazi ahlobene...